If you rely on NewsGuard’s ratings, you may decide to entirely skip by those with a low “red” rating in favor of the “more trustworthy” green-rated articles — and therein lies the problem. NewsGuard is in itself fraught with conflicts of interest, as it’s largely funded by Publicis, a global communications giant that’s partnered with Big Pharma, such that it may be viewed more as a censorship tool than an internet watchdog.



Read more…